Overview

A Double-blind, Randomized, Placebo-controlled Comparison of TAU vs Split Daily Methadone Dosing for Pain Among MMP

Status:
Not yet recruiting

Trial end date:
2028-08-01

Target enrollment:

Participant gender:

Summary

This study will evaluate whether once versus twice daily dosing of methadone will be an effective method for managing comorbid pain and opioid use disorder.

Phase:

Phase 2

Details

Lead Sponsor:

Johns Hopkins University

Collaborator:

National Institute on Drug Abuse (NIDA)

Treatments:

Methadone